Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H9OT
|
|||
| Former ID |
DIB014558
|
|||
| Drug Name |
PfAMA-1
|
|||
| Synonyms |
PfAMA-1-FVO[25-545]; Apical membrane antigen 1 vaccine (Plasmodium infection), African Malaria Network Trust/European Malaria Vaccine Initiative/Biomedical Primate Research Centre; AMA-1 vaccine (malaria), AMANET/EMVI/BPRC
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 1 | [1] | |
| Company |
Biomedical Primate Research Centre
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Plasmodium Apical membrane protein (Malaria AMA-1) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00431808) Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]). U.S. National Institutes of Health. | |||
| REF 2 | Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite devel... J Cell Sci. 2003 Sep 15;116(Pt 18):3825-34. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.